Newbury Pharmaceuticals AB (OSTO:NEWBRY) EV-to-FCF : -2.78 (As of Jun. 10, 2024)

Newbury Pharmaceuticals AB EV-to-FCF Chart

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-FCF	Get a 7-Day Free Trial									-4.60	-2.67	-2.89	-2.34	-3.03

Competitive Comparison of Newbury Pharmaceuticals AB's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Newbury Pharmaceuticals AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newbury Pharmaceuticals AB's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newbury Pharmaceuticals AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Newbury Pharmaceuticals AB's EV-to-FCF falls into.

Newbury Pharmaceuticals AB EV-to-FCF Calculation

Newbury Pharmaceuticals AB's EV-to-FCF for today is calculated as:

Newbury Pharmaceuticals AB's current Enterprise Value is kr71.70 Mil.
Newbury Pharmaceuticals AB's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-25.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newbury Pharmaceuticals AB  (OSTO:NEWBRY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Newbury Pharmaceuticals AB's PE Ratio for today is calculated as:

Newbury Pharmaceuticals AB's share price for today is kr3.22.
Newbury Pharmaceuticals AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.889.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Newbury Pharmaceuticals AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Business Description